Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | RARB | P10826 | 2/20 | 0.36 |
| ▸ | CHKA | P35790 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | RARA | P10276 | 1/20 | 0.31 |
| ▸ | RARG | P13631 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1814580 | 0.91 | RARB (0.40) | PDK2RARBCHKANPC1TP53 | |
| SCHEMBL17407514 | 0.91 | RARB (0.43) | RARBCHKANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL12199003 | 0.90 | RARB (0.48) | RARBTP53HSD17B10RARARARG | |
| SCHEMBL13002328 | 0.89 | PDK2 (0.40) | PDK2CNR1CNR2RARBCHKA | |
| SCHEMBL13002234 | 0.87 | ALOX5 (0.39) | PDK2CNR1CNR2RARBCHKA | |
| SCHEMBL12198989 | 0.86 | RARB (0.40) | RARBCHKANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL15744304 | 0.84 | PDK2 (0.37) | PDK2CNR1CNR2RARBALOX5 | |
| SCHEMBL13002338 | 0.84 | RARB (0.40) | PDK2CNR1CNR2RARBCHKA | |
| SCHEMBL13002235 | 0.84 | PDK2 (0.37) | PDK2CNR1CNR2RARBCHKA | |
| SCHEMBL16562701 | 0.83 | RARB (0.41) | RARBCHKANPC1TP53PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9783735-B2 | Liquid crystal display device and liquid crystal composition used therefor | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-10-10 | — | — | US | disclosed |
| US-9783735-B2 | Liquid crystal display device and liquid crystal composition used therefor | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-10-10 | — | — | US | disclosed |
| EP-3222696-A2 | LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL COMPOSITION USED THEREFOR | Samsung Display Co., Ltd. (KR) | 2017-09-27 | — | — | EP | disclosed |
| US-20160304783-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL COMPOSITION USED THEREFOR | DONGJIN SEMICHEM CO., LTD. (KR) | 2016-10-20 | — | — | US | disclosed |
| US-20160304783-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL COMPOSITION USED THEREFOR | DONGJIN SEMICHEM CO., LTD. (KR) | 2016-10-20 | — | — | US | disclosed |
| EP-3081621-A2 | LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL COMPOSITION USED THEREFOR | Samsung Display Co., Ltd. (KR) | 2016-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160304783-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL COMPOSITION USED THEREFOR | SLC39A11, CYP4F11, WEE1 | PDK2 1599/4885CNR1 1118/4885CNR2 1784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.